National Medical Centre Siglo XXI Mexican Institute for Social Security Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2009
NCT01072799
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Centro Medico Nacional Siglo XXI IMSS | Specialities Hospital, National Medical Centre Siglo XXI Mexican Institute for Social Security (IMSS)

Active Ingredients

Drugs in Phase 3 Trials (2)

dapagliflozin (farxiga) (1 trial)

metformin (glucophage) (1 trial)

Drugs in Phase 2 Trials (1)

inactivated influenza vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Glucose Intolerance (Phase 3)

Influenza, Human (Phase 2)

Obesity (Phase 3)

Obesity, Morbid (Phase 3)

Prediabetic State (Phase 3)

Weight Loss (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3